Type 2 Diabetes Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults aged 18 to 65 years old
• People who have been diagnosed with Type 2 Diabetes
• People whose glycated hemoglobin (a measure of blood sugar control over time) is between 7% and 11%
• People who are overweight or obese, with a BMI between 25 and 40
• People who are currently taking diabetes medication (tablets or insulin) to lower blood sugar
• People whose weight has been relatively stable (within about 5% variation) for at least 12 weeks before the screening visit
• People who have not followed a formal diet program in the last 6 months
• People who are able to understand and follow the study's activities and proposals
• People who are willing and able to sign a written consent form and follow the study's requirements

Who may not be able to join:

• People who have Type 1 diabetes
• People who have eye disease (retinopathy) that affects their vision and limits their ability to participate in the study activities
• People who have serious kidney disease (where kidney filtration is below a certain level)
• People who have liver failure or chronic viral hepatitis (a liver infection)
• People who have severe heart failure (Grade III or IV)
• People who have an active or worsening brain or nerve disease (such as a neurodegenerative condition)
• People who have had a stroke that left lasting effects
• People who are taking medications that affect blood sugar levels or cause weight loss (for example, corticosteroids or immunosuppressants)
• People who have taken steroid tablets or injections for more than 7 consecutive days within the 4 weeks before screening
• People who have taken weight-loss medications (such as orlistat, sibutramine, topiramate, bupropion, liraglutide, or semaglutide) within the 12 weeks before screening
• People taking thyroid hormone medication whose dose has not been stable for at least 12 weeks before screening
• People who have had an active problem with substance misuse, including alcohol, within the last year
• People whose thyroid stimulating hormone (TSH) level is outside the normal range
• People with very high fasting triglyceride (a type of fat in the blood) levels of 600 mg/dL or above
• People who have been diagnosed with or treated for cancer in the last 5 years (with some exceptions such as certain skin cancers — confirm with trial site)
• People who have a serious psychiatric illness
• People who have, or are at risk of, an eating disorder
• Women who are pregnant, planning to become pregnant during the study, or currently breastfeeding
• People who have had recent severe high blood sugar symptoms such as excessive thirst, frequent urination, or unexplained weight loss in the last 3 months
• People who have experienced serious diabetes complications such as diabetic ketoacidosis or hyperosmolar coma
• People the study investigators consider unlikely to complete the full study or be reliable participants
• People who work night shifts finishing after 10pm
• People who are currently following a vegetarian, vegan, or flexitarian diet
• People who have previously had bariatric (weight loss) surgery
• People who are living with HIV
• People who have any other medical condition that investigators believe could interfere with their ability to complete the study or affect the safety and reliability of results
• People who require any treatment during the study that could affect the study's results or the safety of the data collected

Important: Always verify eligibility with the trial site directly before applying.